The short answer

Manufacturer savings cards for Wegovy and Zepbound legally cannot be used if you have Medicare. For weight loss on Medicare, the $50 GLP-1 Bridge is the path — copay cards are not.

This surprises almost everyone. You see "pay as little as $25 a month" on the drugmaker's website, but the fine print excludes Medicare, Medicaid, and every other government plan. If you have Medicare, that offer is not for you — and understanding why saves a lot of wasted phone calls. Check whether the Bridge fits you first with our 60-second eligibility quiz.

Why copay cards exclude Medicare

Manufacturer copay cards (also called savings cards or copay coupons) are discounts the drug company gives to people with commercial (private) insurance. Federal law — the Anti-Kickback Statute — prohibits drugmakers from using these cards for anyone on a government health program. It is not the drug company being difficult; it is illegal for them to do otherwise.

The official terms say so plainly. Novo Nordisk's own Wegovy price guide footnotes the $25 offer with "Government beneficiaries excluded." Lilly's Zepbound savings program requires commercial insurance and states you cannot be enrolled in Medicare, Medicaid, or TRICARE. Same rule, both drugs.

So if a website quotes you a $25 or $199 "savings card" price, mentally add: only if you have private insurance through work or the marketplace — not Medicare.

The three ways to pay for a GLP-1 on Medicare

Here is the honest menu once you are on Medicare and want a GLP-1 for weight loss:

  1. The $50 Medicare GLP-1 Bridge — a flat $50 per month for Wegovy, Zepbound (KwikPen only), or Foundayo, if you meet the clinical criteria. This is almost always the cheapest route. See how much the Bridge costs and which drugs it covers.
  2. Regular Part D coverage — but only if you take the GLP-1 for a condition Medicare already covers, such as type 2 diabetes, sleep apnea, or heart disease. For weight loss alone, standard Part D does not cover these drugs, which is exactly the gap the Bridge fills.
  3. Cash / self-pay — paying the manufacturer's self-pay price yourself. This is the fallback if you do not qualify for the Bridge.

What self-pay actually costs (2026)

If the Bridge is not an option, self-pay is the realistic comparison — not the copay-card price you cannot use. As of mid-2026, the manufacturers' direct self-pay prices run roughly:

  • Wegovy through NovoCare: about $149–$349 per month depending on dose and whether it is the pill or the injection.
  • Zepbound through LillyDirect: about $299–$449 per month depending on dose.

Even the low end of self-pay is several times the Bridge's flat $50. That is why, for anyone who qualifies, the Bridge wins clearly. If you do not qualify, our guide on what to do if you don't qualify walks through the cash-pay and telehealth options.

A common mix-up: "copay support" vs. the Bridge

People searching "bridge program vs copay support" are usually comparing two things that do not actually compete for Medicare members — because copay support is off the table. The real comparison for you is Bridge vs. self-pay, and the Bridge is dramatically cheaper. Do not spend time trying to make a manufacturer card work with Medicare; it will be declined at the pharmacy every time.

What lowers your cost the honest way

  • Confirm Bridge eligibility. The clinical criteria hinge on your BMI at the time you started therapy plus certain conditions — details in our conditions that lower your BMI threshold guide.
  • Get the prescription written for a covered formulation. For Zepbound, that means the KwikPen — single-dose pens and vials are not covered by the Bridge.
  • Ask about Extra Help for your other drugs. Extra Help does not reduce the flat $50 Bridge copay, but it can lower costs on your other Part D medications — see Extra Help and Medicaid.

Data note

Data as of July 2026, verified against Novo Nordisk and Eli Lilly official savings/self-pay terms and CMS.gov Bridge pages. Prices and program terms change often — confirm current figures with the manufacturer, your plan, or 1-800-MEDICARE. This article is educational and is not medical advice.